Application segmentation of the ophiopogon extract market is organized around four primary end‑use categories: cosmetics, pharmaceuticals, nutraceuticals, and food & beverage. In the cosmetics segment, the extract is valued for its antioxidant and skin‑brightening properties, driving roughly 35 % of total revenue as formulators incorporate it into anti‑aging creams and serums. The pharmaceutical segment accounts for about 30 % of the market, where the extract’s anti‑inflammatory and cardioprotective activities support the development of prescription and over‑the‑counter products. Nutraceuticals contribute approximately 20 % of sales, reflecting consumer demand for functional supplements that leverage the herb’s adaptogenic and immune‑modulating effects. The food & beverage segment, though smaller at 15 % of market size, is expanding as manufacturers add the extract to functional beverages and fortified foods for its health‑promoting claims. Collectively, these application sub‑segments define the overall market footprint and guide resource allocation for R&D and commercialization. This analysis aligns with standard market taxonomy practices for ophiopogon extract segmentation.